GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
12.72
+0.03 (0.24%)
At close: Dec 18, 2025, 4:00 PM EST
12.60
-0.12 (-0.94%)
After-hours: Dec 18, 2025, 6:49 PM EST
GH Research Market Cap
GH Research has a market cap or net worth of $789.01 million as of December 18, 2025. Its market cap has increased by 74.71% in one year.
Market Cap
789.01M
Enterprise Value
495.71M
1-Year Change
74.71%
Ranking
Category
Stock Price
$12.72
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has decreased from $808.33M to $789.01M, a decrease of -2.39%. That is a compound annual growth rate of -0.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 787.15M | 116.13% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | 808.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.68B |
| Johnson & Johnson | 501.62B |
| AbbVie | 396.87B |
| UnitedHealth Group | 295.64B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 248.43B |
| Abbott Laboratories | 217.78B |